This work has been carried out to explore the reaction of 2-cyanoacetohydrazide with cyclohexanone to form 4,5,6,7-tetrahydroindole derivatives. 2-Hydroxy-4,5,6,7-tetrahydro-1H-indole-3-carbonitrile was used as the starting material for a series of novel heterocyclic products containing fused oxazine, pyran, pyrazole, pyridazine, and thiophene rings. The antitumor activity evaluation of the newly synthesized compounds against three human tumor cells lines, breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460), and CNS cancer (SF-268), and with normal fibroblast cells (WI 38) showed that some of these compounds exhibit much higher inhibitory effects towards the three tumor cell lines than the reference drug doxorubicin while being minimally active towards normal cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
M. K. Chung, S.-S. Han, and J. C. Kim, Regul. Toxicol. Pharmacol., 45, 273 (2006).
A. De Vizcaya-Ruiz, A. Rivero-Müller, L. Ruiz-Ramirez, J. A. Howarth, and M. Dobrota, Toxicology, 194, 103 (2003).
U. Sanyal, R. Nanda, S. Samanta, A. Pain, S. Dutta, A. S. Verma, B. J. Rider, and K. C. Agrawal, Cancer Lett., 155, 89 (2000).
B. P. Bandgar and S. S. Gawande, Bioorg. Med. Chem., 18, 2060 (2010).
B. K. Banik and F. F. Becker, Eur. J. Med. Chem., 45, 4687 (2010).
W. R. Strohl, Drug Discovery Today, 5, 39 (2000).
B. B. Mishra and V. K. Tiwari, Eur. J. Med. Chem., 46, 4769 (2011).
U. Galm and B. Shen, Chem. Biol. (Oxford, U. K.), 14, 1098 (2007).
G. Ciciani, M. Coronnello, G. Guerrini, S. Selleri, M. Cantore, P. Failli, E. Mini, and A. Costanzo, Bioorg. Med. Chem., 16, 9409 (2008).
D. Kumar, G. Patel, E. O. Johnson, and K. Shah, Bioorg. Med. Chem. Lett., 19, 2739 (2009).
S. Vogel, D. Kaufmann, M. Pojarová, C. Müller, T. Pfaller, S. Kühne, P. J. Bednarski, and E. von Angerer, Bioorg. Med. Chem., 16, 6436 (2008)
D. Kaufmann, M. Pojarová, S. Vogel, R. Liebl, R. Gastpar, D. Gross, T. Nishino, T. Pfaller, and E. Von Angerer, Bioorg. Med. Chem., 15, 5122 (2007).
A. K. Halder, N. Adhikari, and T. Jha, Bioorg. Med. Chem., 56, 571 (2001).
B. Narayana, B. V. Ashalatha, K. K. Vijaya Raj, J. Fernandes, and B. K. Sarojini, Bioorg. Med. Chem., 13 , 4638 (2005).
F. M. Abdelrazek, A. M. Salah El-Din, and A. E. Mekky, Tetrahedron, 57 , 1813 (2001).
R. Ghahremanzadeh, S. Ahadi, and A. Bazgir, Tetrahedron Lett., 50 , 7379 (2009).
G. M. Castanedo and D. P. Sutherlin, Tetrahedron Lett., 42, 7181 (2001).
Z.Puterová, A. Andicsová, and D. Végh, Tetrahedron, 64, 11262 (2008).
K. M. Parida and D. Rath, J. Mol. Catal. A: Chem., 310, 93 (2009).
D. Jain, M. Mishra, and A. Rani, Fuel Process. Technol., 95, 119 (2012).
Z. N. Tisseh, M. Dabiri, M. Nobahar, H. R. Khavasi, and A. Bazgir, Tetrahedron, 68 1769 (2012).
K. Rad-Moghadam and L.Youseftabar-Miri, Tetrahedron, 67, 5693 (2011).
M. S. Christodoulou, S. Liekens, K. M. Kasiotis, and S. A. Haroutounian, Bioorg. Med. Chem., 18, 4338 (2010).
M. R. Boyd and K. D. Paull, Drug Dev. Res., 34, 91(1995).
P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenny, and M. R. Boyd, J. Natl. Cancer Inst., 82, 1107 (1990).
A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paull, D. Vistica, C. Hose, J. Langley, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo, and J. M. Boyd, J. Natl. Cancer Inst., 83, 757 (1991).
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Khimiya Geterotsiklicheskikh Soedinenii, No. 8, pp. 1299-1310, August, 2013.
Rights and permissions
About this article
Cite this article
Mohareb, R.M., Abdelaziz, M.A. Substituted 4,5,6,7-tetrahydroindoles and their fused derivatives. Synthesis and cytotoxic activity towards tumor and normal human cell lines. Chem Heterocycl Comp 49, 1212–1223 (2013). https://doi.org/10.1007/s10593-013-1365-3
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10593-013-1365-3